FindTrial
Sign In

Effect of the primary posterior tracheopexy in esophageal atresia on respiratory tract infections: a randomized controlled trial

Effect of the primary posterior tracheopexy in esophageal atresia on respiratory tract infections: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064676
Enrollment
Unknown
Registered
2022-10-14
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Atresia

Interventions

Intervention group:Posterior tracheopexy
Control group:End-to-end anastomosis of esophagus

Sponsors

Hunan Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 5 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as type III esophageal atresia; 2. Birthweight equal or greater than 1500 grams; 3. Birthweek equal or greater than 33 weeks; 4. Moderate to severe tracheomalacia or broncheomalacia by pre-surgey flexible bronchoscopy.

Exclusion criteria

Exclusion criteria: 1. Give up surgery; 2. Combined with major heart malinformation; 3. Combined with congenital pulmonary malinformation.

Design outcomes

Primary

MeasureTime frame
Respiratorytract infection;—

Secondary

MeasureTime frame
Postoperative mechanical ventilation time;Blood oxygen saturation;Hospitalization days;—

Countries

China

Contacts

Public ContactChonggao Zhou

Hunan Children's Hospital

zhouchonggao@sina.com+86 0731-85356310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026